We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide for Indian patients on understanding the cost of Ocrevus, factors influencing its price, insurance coverage, and available financial assistance programs for managing multiple sclerosis.

Ocrevus (ocrelizumab) is a vital medication for adults diagnosed with certain forms of multiple sclerosis (MS), including relapsing forms of MS (RMS) and primary progressive MS (PPMS). While its effectiveness in managing MS is well-established, understanding the financial aspect, particularly the cost of Ocrevus in India, can be a significant concern for patients and their families. This guide aims to provide a comprehensive overview of Ocrevus pricing, factors influencing the cost, and potential avenues for financial assistance, tailored for an Indian audience.
Ocrevus is a prescription medication that belongs to a class of drugs called monoclonal antibodies. It works by targeting and depleting specific types of immune cells called B cells. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers in the brain and spinal cord. By reducing the number of B cells, Ocrevus helps to decrease inflammation and slow down the progression of the disease. It is administered intravenously, typically every six months, after an initial dosing schedule.
The cost of Ocrevus in India, like any high-value biologic medication, can be influenced by several factors:
Providing an exact figure for the cost of Ocrevus in India is challenging due to the dynamic nature of pricing and the factors mentioned above. However, it is generally considered a high-cost medication. Patients can expect the cost to be in the range of several lakhs of Indian Rupees per year, depending on the factors discussed. It is essential for patients to consult directly with their treating neurologist and the hospital's pharmacy or billing department for the most accurate and up-to-date pricing information.
Navigating health insurance for expensive treatments like Ocrevus can be complex. Here's what Indian patients should consider:
Recognizing the financial burden, several avenues for assistance may be available:
Actionable Step: Contact the pharmaceutical company marketing Ocrevus in India directly. Ask about their patient support programs and eligibility criteria. Also, discuss potential financial assistance options with your neurologist and the hospital's social worker or patient support services.
Ocrevus is a biologic drug, meaning it is derived from living organisms. Currently, there are no generic versions of Ocrevus available. Biosimilars, which are highly similar versions of biologic drugs, are also not yet available for Ocrevus. This means that patients currently have limited options for more affordable alternatives to Ocrevus.
If you have been diagnosed with MS and are considering Ocrevus as a treatment option, or if you are already on Ocrevus and concerned about the cost, it is essential to have an open and honest conversation with your neurologist. They can provide:
The cost per dose can vary significantly. A single infusion might cost several tens of thousands to over a lakh of Indian Rupees, excluding the cost of medical consultation and administration. The total annual cost will depend on the number of infusions required.
Currently, Ocrevus is a high-cost specialty drug, and its availability through standard government healthcare schemes might be limited. However, it's advisable to check with local government hospitals and health authorities for any specific programs or pilot projects that might offer access or subsidies.
Eligibility for financial assistance programs typically depends on factors like income, insurance status, and medical necessity. The best approach is to contact the manufacturer's patient assistance program directly and provide the required documentation. Your doctor's office may also be able to assist you in this process.
Common side effects include infusion-related reactions (like itching, rash, or difficulty breathing), upper respiratory tract infections, and an increased risk of certain infections. Your doctor will monitor you closely for any adverse reactions. It's crucial to discuss all potential side effects with your healthcare provider.
Coverage varies widely among insurance plans. While some comprehensive policies may cover Ocrevus, it's essential to verify the specifics of your policy, including any co-pays, deductibles, or pre-authorization requirements. Contacting your insurance provider directly is the most reliable way to confirm coverage.
Disclaimer: This information is intended for general guidance only and does not constitute medical or financial advice. The cost of Ocrevus and available assistance programs can change. Always consult with your healthcare provider, insurance company, and the pharmaceutical manufacturer for the most accurate and personalized information.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026